ACBM.US ACRO Biomedical Co Ltd

Financial Services Health Care Providers & Services USA Stocks
0.0260 USD
Close of Oct 13, 2026
0.0007 0.0360
Market cap
USD 1.56M
P/E
-
P/B
518.48x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is ACBM.US undervalued?

Graham number

The Graham number of ACRO Biomedical Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ACRO Biomedical Co Ltd fundamental analysis

No fundamental analysis for ACRO Biomedical Co Ltd yet.

ACRO Biomedical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ACRO Biomedical Co Ltd

Acro Biomedical Co., Ltd. engages in the development and marketing of nutritional products in Indiana and internationally. It is involved in the development and sale of cordyceps related products, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.

Full company profile